

Angelini Pharma Switzerland Information
Summary
Angelini Pharma Switzerland is a private company that has been in the industry for 6 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. The position of the President & CEO is occupied by Mark Altmeyer. Its headquarters is located at Zug, Zug, CH. The number of employees ranges from 100 to 250. The annual revenue of Angelini Pharma Switzerland varies between 25M and 100M. Total funding of the company - $222.7M. To connect with Angelini Pharma Switzerland employee register on SignalHire.
Industries
Pharmaceuticals
Headquarters Location
Employees Size
1000-5000 employees
Specialties
Pharmaceuticals, Epilepsy, brain health, focal onset seizures, CNS, Depression, Pain Management, Anti-inflammation, Seizure freedom, Healthcare, Consumer Health, OTC
SIC Code
2834
Founded
2021
Estimated Annual Revenue
$25M - 100M
Operating Status
Acquired
Contact Angelini Pharma Switzerland
Organization Website
Social Links
Phone Number
+41 (0) 417115882
Competitors
Founded | Type | Employees | Revenue | Funding | |
---|---|---|---|---|---|
1999 | Public Company | 25 - 100 | 7.9M | $105.4M | |
2010 | Public Company | 250 - 500 | 1.1B | $843M | |
2014 | Public Company | 100 - 250 | 132.2M | $267.1M | |
1993 | Public Company | 500 - 1.0K | 573.5M | $201M | |
2007 | Public Company | 1 - 25 | 41.2M | $124.3M | |
2001 | Public Company | 25 - 100 | 5M | $181.3M | |
2001 | Privately Held | 100 - 250 | 5M | $126.7M | |
1999 | Nonprofit | 25 - 100 | 3.9M | $0 | |
1998 | - | 1 - 25 | 17.9M | $0 |